differs from all other known clay minerals
It is concluded that the Kisameet Bay deposit is an aluminum silicate, which differs from all other known clay minerals not only in its composition but also in its properties. This product, therefore, deserves special attention not only from a geological and mineralogical point of view but also from a colloid chemical and very definitely from a medical point of view.
Dr. Ernst Hauser, Professor of Chemistry, MIT
ACADEMIC & COMMERCIAL RESEARCH
exhibits antimicrobial properties
Compositional analysis of the clay to identify active components is ongoing at 4D LABS at Simon Fraser University, led by Dr. Neil Branda and Dr. Dirk Lange. Initial discoveries of the antimicrobial properties of the clay have advanced to further studies of the multifactorial biological activity of the mineral.
PRECLINICAL TRIALS UNDERWAY
potential for novel therapeutic applications
In mid 2020 the company entered into Preclinical Studies with Althea DRF Life Sciences targeting inflammation and immunomodulation. Mineral nutrition can optimize skin health and historically skin treatments have used clay-based ingredients. Kisolite is a novel mineral complex with promising applications for inflammation and immunomodulation therapies. Kisolite is a highly functional bioactive ingredient from which multiple health and wellness products can be commercialized. Dr. Dirk Lange
CLINICAL TRIALS PLANNING
multiple applications under consideration
The opportunities to conduct clinical trials in order to introduce new, natural therapies across a broad spectrum of health needs are being prioritized. Dr. Neil Branda
Dr. Neil Branda, Ph.D. Chemistry, MIT
Neil Branda is a Professor of Chemistry at Simon Fraser University and Scientific Director of 4D LABS, a research center for advanced materials and nanoscale devices.
Dr. Branda's expertise lies at the interface of organic chemistry and materials science with a focus on designing and synthesizing molecular switches (molecules that change their structure and function when triggered with light, electricity or other stimuli). He is one of Canada's leading materials scientists, is a 2006 Canada's Top 40 Under 40 recipient, a 2005 NSERC Steacie Fellowship winner, and a Tier I Canada Research Chair in Materials Science.
Dr. Dirk Lange, Ph.D. Microbiology & Immunology
Dirk Lange is a microbiologist who earned his Ph.D. (honours) in Microbiology and Immunology from the University of Western Ontario (London, Ontario) on understanding the role of the capsular polysaccharide in the pathogenesis of Campylobacter jejuni.
Dr. Lange is involved in collaborative work at Vancouver General Hospital in the area of ureteral stent associated morbidity, with specific emphasis on biomaterial design and the development of mechanisms that prevent bacterial adhesion, colonization, and biofilm formation.